Lynnette K. Nieman

Active 1985–2025

140
Papers
30,851
Citations
91
h-index
138
i10-index

Citations

Citations per year for Lynnette K. Nieman1985: 3 citations1986: 2 citations1987: 23 citations1988: 31 citations1989: 28 citations1990: 25 citations1991: 48 citations1992: 38 citations1993: 42 citations1994: 55 citations1995: 51 citations1996: 56 citations1997: 55 citations1998: 87 citations1999: 91 citations2000: 95 citations2001: 111 citations2002: 135 citations2003: 136 citations2004: 140 citations2005: 214 citations2006: 177 citations2007: 182 citations2008: 194 citations2009: 218 citations2010: 181 citations2011: 208 citations2012: 180 citations2013: 208 citations2014: 209 citations2015: 298 citations2016: 207 citations2017: 143 citations2018: 147 citations2019: 662 citations2020: 693 citations2021: 674 citations2022: 594 citations2023: 343 citations2024: 532 citations2025: 250 citations2026: 8 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,020 citing papers, 29.4% of this breakdownItaly: 541 citing papers, 7.9% of this breakdownUnited Kingdom: 519 citing papers, 7.6% of this breakdownGermany: 382 citing papers, 5.6% of this breakdownFrance: 303 citing papers, 4.4% of this breakdownCanada: 289 citing papers, 4.2% of this breakdownNetherlands: 269 citing papers, 3.9% of this breakdownChina: 266 citing papers, 3.9% of this breakdownAustralia: 174 citing papers, 2.5% of this breakdownSpain: 157 citing papers, 2.3% of this breakdownSwitzerland: 153 citing papers, 2.2% of this breakdownSweden: 143 citing papers, 2.1% of this breakdown
0%29.4%Other 24%

Fields

  • Medicine75.8%
  • Neuroscience12.9%
  • Biochemistry, Genetics and Molecular Biology5.9%
  • Psychology2.6%
  • Immunology and Microbiology0.7%
  • Health Professions0.3%
  • Other1.8%

Topics

  • Pituitary Gland Disorders and Treatments10.9%
  • Adrenal Hormones and Disorders8%
  • Stress Responses and Cortisol6.4%
  • Adrenal and Paraganglionic Tumors5.9%
  • Hormonal Regulation and Hypertension4.1%
  • Growth Hormone and Insulin-like Growth Factors2.8%
  • Other61.9%

Coauthors

All papers

Open in search
  1. The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline

    Authors: , , , , , , - European Journal of Endocrinology 2008 cited by 2,678

  2. Consensus on diagnosis and management of Cushing's disease: a guideline update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Newell‐Price, Lynnette K. Nieman, Alberto M. Pereira, Stephan Petersenn, Rosario Pivonello, Hershel Raff, Martín Reincke, Roberto Salvatori, Carla Scaroni, Ilan Shimon, Constantine A. Stratakis, Brooke Swearingen, Antoine Tabarin, Yutaka Takahashi, Marily Theodoropoulou, Stylianos Tsagarakis, Elena Valassi, Elena V Varlamov, Greisa Vila, John Wass, Susan M. Webb, Maria Chiara Zatelli, Biller, BMK - 2021 cited by 351

  3. Cushing's syndrome

    Authors: , , , - The Lancet 2015 cited by 1,740

  4. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline

    Authors: , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2015 cited by 1,247

  5. Effects of Gonadal Steroids in Women With a History of Postpartum Depression

    Authors: , , , , , - American Journal of Psychiatry 2000 cited by 943

  6. Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels

    Authors: , , , , , , , - American Journal of Psychiatry 2017 cited by 204

  7. Cushing's syndrome

    Authors: , , , - The Lancet 2006 cited by 1,154

  8. Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression

    Authors: , , , , , , , , - JAMA Psychiatry 2015 cited by 250

  9. Differential Behavioral Effects of Gonadal Steroids in Women with and in Those without Premenstrual Syndrome

    Authors: , , , , - New England Journal of Medicine 1998 cited by 767

  10. Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement

    Authors: , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2003 cited by 1,365

  11. Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2008 cited by 860

  12. Cushing’s Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years’ Experience at the National Institutes of Health

    Authors: , , , , , - The Journal of Clinical Endocrinology & Metabolism 2005 cited by 711

  13. Cushing's disease: pathobiology, diagnosis, and management

    Authors: , , - Journal of neurosurgery 2016 cited by 206

  14. Advances in the medical treatment of Cushing's syndrome

    Authors: , , , , , - The Lancet Diabetes & Endocrinology 2018 cited by 149

  15. Cushing's syndrome: update on signs, symptoms and biochemical screening

    Authors: - European Journal of Endocrinology 2015 cited by 342

  16. A Phase 2 Study of Chronocort, a Modified-Release Formulation of Hydrocortisone, in the Treatment of Adults With Classic Congenital Adrenal Hyperplasia

    Authors: , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2014 cited by 161

  17. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder

    Authors: , , , , , , , , , - Neuropsychopharmacology 2015 cited by 145

  18. Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Reviews Endocrinology 2023 cited by 32

  19. Estrogen replacement in perimenopause-related depression: A preliminary report

    Authors: , , , , , , - American Journal of Obstetrics and Gynecology 2000 cited by 577

  20. The Hypothalamic-Pituitary-Adrenal Axis in Pregnancy: Challenges in Disease Detection and Treatment

    Authors: , - Endocrine Reviews 2005 cited by 449

  21. Cushing's syndrome: epidemiology and developments in disease management

    Authors: , , - Clinical Epidemiology 2015 cited by 206

  22. The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder

    Authors: , , , , , , , , - Molecular Psychiatry 2017 cited by 96

  23. Approach to the Patient Treated with Steroidogenesis Inhibitors

    Authors: , , , - The Journal of Clinical Endocrinology & Metabolism 2021 cited by 74

  24. Metyrapone Treatment in Endogenous Cushing’s Syndrome: Results at Week 12 From PROMPT, a Prospective International Multicenter, Open-Label, Phase III/IV Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the Endocrine Society 2021 cited by 39